Harrow Inc header image

Harrow Inc

HROW

Equity

ISIN null / Valor 45675535

NASDAQ (2026-05-05)
USD 40.50+0.75%

Harrow Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Harrow Inc. is a prominent player in the ophthalmic healthcare sector, specializing in the development and distribution of pharmaceutical products for eye care. The company caters to the needs of over 10,000 healthcare providers, including doctors, hospitals, and ambulatory surgical centers, by supplying medications for a range of eye conditions such as dry eye disease, glaucoma, allergies, infections, and other inflammatory conditions. Harrow's products are integral to the over 8 million ophthalmic surgeries conducted annually in the United States. The company operates a comprehensive national sales and customer service network, supported by a robust production and distribution infrastructure that is licensed across all 50 states, ensuring efficient delivery to more than 1,500 institutional accounts each month.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

63.8%1Y
49.4%3Y
427%5Y

Performance

66.6%1Y
74.5%3Y
69.2%5Y

Volatility

Market cap

1508 M

Market cap (USD)

Daily traded volume (Shares)

442,566

Daily traded volume (Shares)

1 day high/low

33.62 / 32.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 301.11
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 297.49
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%USD 168.71
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.35%USD 121.32
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 50.44
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 15.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 56.95
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.58%USD 10.61
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.73%USD 232.30
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 16.75